Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Robertson

Showing results (521-530 of 565) with videos related to

Pageof 57
Sort By:
The Journal of Antimicrobial Chemotherapy|October 14, 2017
Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal diseaseOliver A Cornely, Michael N Robertson, Shariq Haider, et al.
The Journal of Antimicrobial Chemotherapy|September 30, 2017
Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal diseaseOliver A Cornely, Michael N Robertson, Shariq Haider, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 23, 2006
Kidney cancer. Clinical practice guidelines in oncologyRobert J Motzer, Graeme B Bolger, Barry Boston, et al.
AIDS (London, England)|March 6, 2026
Islatravir distribution in plasma, peripheral blood mononuclear cells, and mucosal tissues after monthly oral dosingCraig W Hendrix, Sharon L Hillier, Linda-Gail Bekker, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 23, 2006
Testicular cancer. Clinical practice guidelines in oncologyRobert J Motzer, Graeme B Bolger, Barry Boston, et al.
The Journal of Infectious Diseases|May 6, 2025
Safety, Tolerability, and Pharmacokinetics of Once-Monthly Oral Islatravir: a Phase 2a Study in Participants at Low Risk for Acquiring HIV-1Sharon L Hillier, Linda-Gail Bekker, Sharon A Riddler, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 10, 2009
Testicular cancer. Clinical practice guidelinesRobert J Motzer, Robert R Bahnson, Barry Boston, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 10, 2009
Kidney cancer. Clinical practice guidelinesRobert J Motzer, Michael A Carducci, Mayer Fishman, et al.
Annals of Internal Medicine|August 8, 2022
Reinfection and Risk Behaviors After Treatment of Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy : A Cohort StudyJason Grebely, Gregory J Dore, Frederick L Altice, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 25, 2008
Safety and immunogenicity of a replication-incompetent adenovirus type 5 HIV-1 clade B gag/pol/nef vaccine in healthy adultsFrances H Priddy, Deborah Brown, James Kublin, et al.
Pageof 57

Showing results (521-530 of 565) with videos related to

Sort By:
Pageof 57
The Journal of Antimicrobial Chemotherapy|October 14, 2017
Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal diseaseOliver A Cornely, Michael N Robertson, Shariq Haider, et al.
The Journal of Antimicrobial Chemotherapy|September 30, 2017
Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal diseaseOliver A Cornely, Michael N Robertson, Shariq Haider, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 23, 2006
Kidney cancer. Clinical practice guidelines in oncologyRobert J Motzer, Graeme B Bolger, Barry Boston, et al.
AIDS (London, England)|March 6, 2026
Islatravir distribution in plasma, peripheral blood mononuclear cells, and mucosal tissues after monthly oral dosingCraig W Hendrix, Sharon L Hillier, Linda-Gail Bekker, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 23, 2006
Testicular cancer. Clinical practice guidelines in oncologyRobert J Motzer, Graeme B Bolger, Barry Boston, et al.
The Journal of Infectious Diseases|May 6, 2025
Safety, Tolerability, and Pharmacokinetics of Once-Monthly Oral Islatravir: a Phase 2a Study in Participants at Low Risk for Acquiring HIV-1Sharon L Hillier, Linda-Gail Bekker, Sharon A Riddler, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 10, 2009
Testicular cancer. Clinical practice guidelinesRobert J Motzer, Robert R Bahnson, Barry Boston, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 10, 2009
Kidney cancer. Clinical practice guidelinesRobert J Motzer, Michael A Carducci, Mayer Fishman, et al.
Annals of Internal Medicine|August 8, 2022
Reinfection and Risk Behaviors After Treatment of Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy : A Cohort StudyJason Grebely, Gregory J Dore, Frederick L Altice, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 25, 2008
Safety and immunogenicity of a replication-incompetent adenovirus type 5 HIV-1 clade B gag/pol/nef vaccine in healthy adultsFrances H Priddy, Deborah Brown, James Kublin, et al.
Pageof 57